Biosensors Europe SA
Quick facts
Phase 3 pipeline
- Dual Anti Platelet Therapy · Cardiovascular
Dual antiplatelet therapy combines two antiplatelet agents to inhibit platelet aggregation through different mechanisms, reducing thrombotic events.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: